 Nicole Marjon
Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, G-Protein-Coupled | 3 | 2014 | 200 | 0.540 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2014 | 30 | 0.460 |
Why?
| | Ovarian Neoplasms | 4 | 2024 | 484 | 0.430 |
Why?
| | Carcinogenesis | 1 | 2014 | 201 | 0.410 |
Why?
| | Tumor Microenvironment | 3 | 2024 | 596 | 0.390 |
Why?
| | Cystadenocarcinoma, Serous | 2 | 2024 | 68 | 0.270 |
Why?
| | Tryptophan Oxygenase | 1 | 2024 | 33 | 0.220 |
Why?
| | Receptors, Formyl Peptide | 2 | 2016 | 6 | 0.210 |
Why?
| | Arrestins | 2 | 2016 | 14 | 0.210 |
Why?
| | Lung Neoplasms | 1 | 2014 | 2357 | 0.180 |
Why?
| | Frozen Sections | 1 | 2019 | 26 | 0.160 |
Why?
| | Sentinel Lymph Node Biopsy | 1 | 2019 | 107 | 0.150 |
Why?
| | Lymphatic Metastasis | 1 | 2019 | 312 | 0.150 |
Why?
| | Endometrial Neoplasms | 1 | 2018 | 163 | 0.130 |
Why?
| | src-Family Kinases | 1 | 2016 | 94 | 0.120 |
Why?
| | CTLA-4 Antigen | 1 | 2015 | 88 | 0.120 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2015 | 89 | 0.110 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2015 | 156 | 0.110 |
Why?
| | Hyperplasia | 1 | 2014 | 171 | 0.110 |
Why?
| | Ovariectomy | 1 | 2014 | 135 | 0.110 |
Why?
| | Receptors, Estrogen | 2 | 2014 | 423 | 0.110 |
Why?
| | Tamoxifen | 1 | 2014 | 198 | 0.110 |
Why?
| | Estrogen Receptor alpha | 1 | 2014 | 131 | 0.110 |
Why?
| | Prognosis | 2 | 2024 | 3793 | 0.100 |
Why?
| | Estrogens | 1 | 2014 | 348 | 0.090 |
Why?
| | Adaptor Protein Complex 2 | 1 | 2009 | 7 | 0.080 |
Why?
| | Growth | 1 | 2009 | 58 | 0.080 |
Why?
| | Mice, Transgenic | 1 | 2014 | 2082 | 0.080 |
Why?
| | Growth Disorders | 1 | 2009 | 78 | 0.080 |
Why?
| | Body Height | 1 | 2009 | 192 | 0.070 |
Why?
| | Malnutrition | 1 | 2009 | 78 | 0.070 |
Why?
| | Cell Proliferation | 1 | 2014 | 2344 | 0.070 |
Why?
| | Macrophages | 2 | 2024 | 1456 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2016 | 2523 | 0.070 |
Why?
| | Apoptosis | 2 | 2016 | 2485 | 0.060 |
Why?
| | Atherosclerosis | 1 | 2009 | 392 | 0.060 |
Why?
| | Body Weight | 1 | 2009 | 936 | 0.060 |
Why?
| | BRCA2 Protein | 1 | 2024 | 53 | 0.060 |
Why?
| | Antineoplastic Agents | 1 | 2015 | 2043 | 0.060 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2024 | 48 | 0.060 |
Why?
| | Animals | 5 | 2024 | 34708 | 0.050 |
Why?
| | Neoplasm Grading | 1 | 2024 | 278 | 0.050 |
Why?
| | Kynurenine | 1 | 2024 | 103 | 0.050 |
Why?
| | Tryptophan | 1 | 2024 | 168 | 0.050 |
Why?
| | B7-H1 Antigen | 1 | 2024 | 175 | 0.050 |
Why?
| | Blood Pressure | 1 | 2009 | 1746 | 0.050 |
Why?
| | Protein Transport | 2 | 2016 | 424 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2024 | 829 | 0.040 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2024 | 510 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2024 | 716 | 0.040 |
Why?
| | Female | 7 | 2024 | 68274 | 0.040 |
Why?
| | Intraoperative Period | 1 | 2019 | 53 | 0.040 |
Why?
| | Pelvic Exenteration | 1 | 2018 | 11 | 0.040 |
Why?
| | Salpingo-oophorectomy | 1 | 2018 | 17 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2024 | 1318 | 0.040 |
Why?
| | Hysterectomy | 1 | 2018 | 118 | 0.040 |
Why?
| | Lymph Node Excision | 1 | 2018 | 166 | 0.040 |
Why?
| | Humans | 9 | 2024 | 129078 | 0.040 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2018 | 380 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 2018 | 657 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2024 | 3114 | 0.030 |
Why?
| | Protein Binding | 2 | 2016 | 2087 | 0.030 |
Why?
| | Mice | 3 | 2024 | 16583 | 0.030 |
Why?
| | Medical Oncology | 1 | 2018 | 273 | 0.030 |
Why?
| | Gynecology | 1 | 2018 | 174 | 0.030 |
Why?
| | Obesity | 1 | 2009 | 2847 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 326 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2015 | 255 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2018 | 1286 | 0.030 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2015 | 216 | 0.030 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2015 | 174 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2018 | 528 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 957 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2018 | 5036 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2015 | 929 | 0.030 |
Why?
| | Immunologic Memory | 1 | 2015 | 337 | 0.030 |
Why?
| | T-Lymphocyte Subsets | 1 | 2015 | 411 | 0.030 |
Why?
| | Aged | 2 | 2024 | 22068 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2015 | 1213 | 0.020 |
Why?
| | Palliative Care | 1 | 2018 | 712 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2015 | 759 | 0.020 |
Why?
| | Phosphorylation | 1 | 2016 | 1686 | 0.020 |
Why?
| | Cell Movement | 1 | 2016 | 935 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2015 | 1974 | 0.020 |
Why?
| | Immunotherapy | 1 | 2015 | 584 | 0.020 |
Why?
| | Middle Aged | 2 | 2024 | 31024 | 0.020 |
Why?
| | U937 Cells | 1 | 2009 | 23 | 0.020 |
Why?
| | Nigeria | 1 | 2009 | 14 | 0.020 |
Why?
| | Mammary Arteries | 1 | 2009 | 7 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2016 | 2774 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2009 | 160 | 0.020 |
Why?
| | World Health Organization | 1 | 2009 | 106 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2015 | 1361 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 292 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2016 | 2702 | 0.020 |
Why?
| | Endosomes | 1 | 2009 | 132 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2016 | 4063 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2009 | 392 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 404 | 0.020 |
Why?
| | Reference Values | 1 | 2009 | 791 | 0.020 |
Why?
| | Transfection | 1 | 2009 | 907 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 7063 | 0.020 |
Why?
| | Blotting, Western | 1 | 2009 | 1189 | 0.020 |
Why?
| | Estradiol | 1 | 2009 | 494 | 0.020 |
Why?
| | Vasodilation | 1 | 2009 | 480 | 0.020 |
Why?
| | Breast Feeding | 1 | 2009 | 424 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2015 | 5282 | 0.010 |
Why?
| | Socioeconomic Factors | 1 | 2009 | 1192 | 0.010 |
Why?
| | Risk Factors | 1 | 2018 | 9804 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2018 | 10256 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2009 | 2311 | 0.010 |
Why?
| | Signal Transduction | 1 | 2016 | 4867 | 0.010 |
Why?
| | Prevalence | 1 | 2009 | 2541 | 0.010 |
Why?
| | Adult | 2 | 2018 | 35423 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2018 | 14562 | 0.010 |
Why?
| | Body Mass Index | 1 | 2009 | 2250 | 0.010 |
Why?
| | Rats | 1 | 2009 | 5254 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2009 | 5707 | 0.010 |
Why?
| | Infant | 1 | 2009 | 8997 | 0.010 |
Why?
| | Child, Preschool | 1 | 2009 | 10462 | 0.010 |
Why?
| | Male | 2 | 2009 | 63248 | 0.010 |
Why?
|
|
Marjon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|